NewsEarningsZenith Healthcare Reports Mixed Q2 Results with Revenue Dip, Profit Growth for H1 FY2026Zenith Healthcare Reports Mixed Q2 Results with Revenue Dip, Profit Growth for H1 FY2026
Zenith Healthcare Limited released its Q2 FY2026 results, showing a 9.6% quarter-on-quarter decline in revenue to ₹302.79 crore and a 9.5% drop in net profit to ₹21.88 crore. However, half-yearly results were more positive, with H1 FY2026 revenue increasing 14% year-over-year to ₹638.58 crore and net profit surging 70.9% to ₹39.34 crore. The company's balance sheet remains strong with total equity of ₹752.92 lakh against total assets of ₹1,072.03 lakh. The Board approved these results on November 11, 2025.
*this image is generated using AI for illustrative purposes only.
Zenith Healthcare Limited , a pharmaceutical trading company, has released its unaudited financial results for the second quarter and first half of the fiscal year 2026, ending September 30, 2025. The results paint a mixed picture of the company's performance, with a quarter-on-quarter revenue decline but a notable improvement in half-yearly profits.
Quarterly Performance
For the quarter ended September 30, 2025, Zenith Healthcare reported:
| Metric | Q2 FY2026 | Q1 FY2026 | QoQ Change |
|---|---|---|---|
| Revenue from Operations | ₹302.79 | ₹335.11 | -9.6% |
| Net Profit | ₹21.88 | ₹24.18 | -9.5% |
| Earnings Per Share | ₹0.02 | - | - |
The company experienced a 9.6% decrease in revenue from operations compared to the previous quarter. Net profit also saw a decline of 9.5% quarter-on-quarter.
Half-Yearly Results
Despite the quarterly dip, the half-yearly results show improvement:
| Metric | H1 FY2026 | H1 FY2025 | YoY Change |
|---|---|---|---|
| Revenue from Operations | ₹638.58 | ₹559.92 | +14.0% |
| Net Profit | ₹39.34 | ₹23.02 | +70.9% |
The company's revenue for the first half of FY2026 grew by 14.0% compared to the same period last year. More impressively, net profit surged by 70.9% year-over-year, indicating improved profitability.
Board Approval and Compliance
The Board of Directors approved these results at a meeting held on November 11, 2025. The financial results were reviewed by the Board of Directors and the Audit Committee before approval. The company has prepared its financial statements in accordance with the Companies (Indian Accounting Standards) Rules, 2015, and in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Segment Information
Zenith Healthcare operates in a single reportable segment - Pharmaceuticals Trading, as per the requirements of Ind AS 108.
Balance Sheet Highlights
As of September 30, 2025, Zenith Healthcare reported:
| Metric | Amount (₹ in Lakhs) |
|---|---|
| Total Assets | 1072.03 |
| Total Equity | 752.92 |
| Current Assets | 706.45 |
| Current Liabilities | 314.89 |
The company maintains a strong equity position, with total equity of ₹752.92 lakh against total assets of ₹1,072.03 lakh.
While Zenith Healthcare faces challenges in its quarterly performance, the overall half-yearly results demonstrate resilience and growth.
Historical Stock Returns for Zenith Health Care
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.36% | -3.96% | -7.38% | -19.82% | -33.70% | -50.81% |
17
